CXApp Inc. (NASDAQ: CXAI)

CXApp Inc. is a leading provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's cloud-based, mobile-first platform integrates artificial intelligence, automation, and real-time analytics to streamline workplace interactions across people, spaces, and technology. By leveraging advanced mapping, location intelligence, and digital workplace tools, CXApp enables organizations to optimize hybrid work environments and foster meaningful employee experiences.

CXApp generates revenue through a SaaS (Software-as-a-Service) model, offering recurring software fees and professional service fees for setup and deployment. The company's primary product is the CXAI Platform, which includes several key components: CXAI Apps, a multi-platform suite of applications offering AI-driven, personalized workflows; CXAI BTS (Behind the Scenes), the core AI engine powering automation, content management, and security compliance; and CXAI-VU, a generative AI analytics platform providing actionable insights into workplace utilization, employee engagement, and productivity. The general customer base consists of Fortune 1000 enterprises primarily in the United States, with deployments globally across industries such as software/technology, financial services, next-gen auto manufacturing, entertainment, and life science companies.

• CXAI Apps: This multi-platform suite of applications (iOS, Android, and web) offers AI-driven, personalized workflows for employees, enhancing productivity and engagement. It caters to the market of enterprise customers looking to streamline workplace interactions and improve employee experiences.

• CXAI BTS (Behind the Scenes): The core AI engine that powers automation, content management, and security compliance for enterprise-wide deployments. This segment serves the market of organizations requiring robust backend support for their digital workplace solutions.

• CXAI-VU: A generative AI analytics platform that provides actionable insights into workplace utilization, employee engagement, and productivity, allowing real-time decision-making. This segment targets enterprises seeking data-driven strategies to optimize their work environments.

CXApp operates in a highly competitive industry, facing competition from specialized SaaS providers focused on workplace optimization, such as Envoy, Modo Labs, Condeco, Robin, and Petur. These competitors offer comprehensive desk booking, space management, and employee experience solutions that directly address hybrid workplace needs. Additionally, CXApp competes with intranet solution providers like Appspace, Workvivo, and Simplrr, as well as large technology-driven entrants like ServiceNow, Microsoft, and Cisco, which are integrating space management and employee experience offerings into their enterprise platforms. CXApp's competitive advantages include its innovative platform, which represents a shift in how organizations engage with their employees and optimize physical spaces, offering a new way to integrate digital workplace tools with physical environments. The company's commitment to innovation and customer success has allowed it to establish a strong presence in key industries.

CXApp's customers include Fortune 1000 enterprises primarily in the United States, with deployments globally across various industries. The company's platform is used to streamline operations in a single mobile app platform, delivering the best possible experience to employees whether they are onsite, in-person, or working remotely. CXApp's unique approach to workplace apps offers customers a feature-rich, white-label experience, allowing the in-app experience to reflect each customer's distinct business goals and brand identity. The company's customers benefit from a robust product that serves multiple uses, backed by native applications, technology partner integrations, and workplace analytics that help employees and operations make data-informed decisions.